Cargando…
The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancer
The phosphatidylinositol-3 kinase (PI3K) pathway regulates a number of cellular processes, including cell survival, cell growth, and cell cycle progression. Consequently, this pathway is commonly deregulated in cancer. In particular, mutations in the gene PIK3CA that encodes the p110α catalytic subu...
Autores principales: | Dumont, Amaury G., Dumont, Sarah N., Trent, Jonathan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777497/ https://www.ncbi.nlm.nih.gov/pubmed/22640628 http://dx.doi.org/10.5732/cjc.012.10032 |
Ejemplares similares
-
PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022) -
Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012) -
2587. Etiology and Outcome of Acute Neonatal Infectious Encephalitis
por: Frankel, Craig, et al.
Publicado: (2019) -
PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis
por: Liu, Yi-Rong, et al.
Publicado: (2014) -
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)